You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Two new studies have delivered a multitude of new markers linked to testicular cancer, as well as a better understanding of the genetic architecture of the disease.
The British molecular diagnostics company plans to make its array-based test for early-stage Alzheimer's disease available in the US by year end.
In PNAS this week: high-altitude adaptation signature among Tibetans, de novo mutations in early-onset high myopia, and more.
The proceeds from the seed round will enable TL Biolabs to fund the development and commercial launch of a $15 genomic test for dairy and beef cattle.
The researchers believe that by monitoring mtDNA copy number in blood, they will be able to identify people at risk for developing CHD who could benefit from preventative efforts.
Researchers analyzed the exomes of metastatic tumor samples from patients who died of breast cancer to piece together the genomic evolution.
Illumina and the H3Africa Consortium hope the array will allow future GWAS to address African genomic diversity in a way that previous chips have not.
Researchers working on the Human Functional Genomics Project have begun to unravel genetic relationships and variations in human immune response.
The company's testing was successful in more than 90 percent of cases over almost four years, and detected a wide variety of abnormalities.
Researchers who developed a DNA displacement and graphene field effect-based method to detect SNPs electrically are setting their sights on implanted probes.
Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.
NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
In Science this week: review discusses advances in liquid biopsies, and more.